Yes, proteins are a major target for cancer therapies. For example, drugs that inhibit tyrosine kinases, a type of protein involved in signal transduction, have been effective in treating certain types of cancer. Monoclonal antibodies can also be designed to target specific proteins on the surface of cancer cells, marking them for destruction by the immune system.
